Novartis Phase II BAF312 in Stroke ICH
Clinical Trial Grant
Administered By
Anesthesiology, Neuroanesthesia
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
May 24, 2018
End Date
September 9, 2020
Administered By
Anesthesiology, Neuroanesthesia
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
May 24, 2018
End Date
September 9, 2020